JUAN RAMIREZ: Open Payments
NPI 1770976912 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,145 in 69 payments from 21 companies in 2025. Trend: 2023 $1,116 · 2024 $971 · 2025 $2,145
Food & beverage: $2,145
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $601 |
| Corcept Therapeutics | 10 | $203 |
| Amgen Inc. | 8 | $167 |
| AstraZeneca Pharmaceuticals LP | 3 | $166 |
| Xeris Pharmaceuticals, Inc. | 8 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $145 |
| Ascendis Pharma Endocrinology Inc | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $88 |
| Gilead Sciences, Inc. | 1 | $68 |
| Tandem Diabetes Care, Inc. | 3 | $60 |
Products named: Ozempic, Korlym, FARXIGA, TEPEZZA, Kerendia, GVOKE HYPOPEN, Wegovy, Yorvipath.
Industry payments across FL — which companies pay providers there.
